Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Biovail Corporation
Biovail Announces Pricing of Offering of US$300 Million Senior Convertible Notes due 2014
June 27th, 2009
Biovail Corporation (NYSE: BVF) announced that its offering of senior convertible notes, which priced today, has been increased and that it has entered into a purchase agreement pursuant to which it will issue US$300 million aggregate principal amount of 5.375% senior convertible notes due 2014 (the "Notes") in a private offering to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Biovail also has granted one of the initial purchasers of the Notes an option to purchase an additional US$50 million aggregate principal amount of such Notes. The Notes are unsecured, senior obligations of Biovail, will...
Source: Law & Health Weekly (2009-06-27)
|
